(Q68039315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

E A Eisenhauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

W K Evans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

N Murray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

W Kocha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

R Wierzbicki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

K Wilson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

20 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

327-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00173653

20 September 2019

exact match

0 references

cites work

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice

1 reference

12 December 2020

Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients

1 reference

12 December 2020

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

12 December 2020

VP-16 and cisplatin as first-line therapy for small-cell lung cancer

1 reference

12 December 2020

Chemotherapy in the treatment of malignant mesothelioma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00173653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3229945%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference